www.vet-webinar.com uses cookies to offer you the best possible service. Read more

Webinars & e-learning courses All webinars

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)
Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)

Cancer frequently affects our veterinary patients and in recent years chemotherapy has become more commonly utilised treatment. General practices are increasingly prescribing and administering chemotherapy drugs. Chemotherapy drugs are toxic to cells (cytotoxic) interfering with the normal cell life cycle which results in cell death. Cancer cells are targeted by these drugs however they are not specific for cancer cells and healthy tissue can be affected.

Chemotherapy drugs are also carcinogenic, mutagenic, teratogenic and abortifacient. It is important that these drugs are handled safely. Personnel handling of chemotherapeutic drugs have been found to have increased risks of infertility, early pregnancy loss or urinary excretion of these drugs. This webinar will discuss the safety precautions necessary for handling chemotherapy agents and will focus on the recent consensus guidelines produced by the American College of Veterinary Internal Medicine (ACVIM) in January 2018 to raise awareness of risks and how we can reduce the exposure within clinics.

If time permits, common side effects (neutropaenia, thorombocytopaenia and gastrointestinal side effects) caused by chemotherapy will be explained as well as precautions for handling such patients.

Recording from 8 August 2019

Speaker:

BVSCMomokoIto_image.jpg

Momoko Ito

Momoko Ito. Veterinary Nurse (VTS, oncology)

Momoko is from Japan and moved to Brisbane in 2006. She completed a Bachelor of Veterinary Technology at the University of Queensland in 2011. She has worked in general practice before working at Brisbane Veterinary Specialist Centre. She started as a full-time rotating nurse at BVSC in 2011, then became BVSC's Primary Chemotherapy Nurse in 2013. Momoko also volunteered at the RSPCA Wildlife Hospital every Saturday for one year as well as taking casual shits at the BVECCS Emergency Centre.
In June 2018, Momoko passed the exam to become a Veterinary Technician Specialist (VTS) in Oncology accredited by the Academy of Internal Medicine Veterinary Technicians in the US. She is currently the first and the only VTS (Oncology) in Australia. Her daily goal is to give our patients the best attentions and care, and also to be the better communication bridge between owners and veterinarians to achieve a good quality of life in cancer patients. Her interest is not only limited to Oncology but also Internal Medicine and Feline Behaviour and Handling.
Momoko grew up with 4-6 cats. She admits being a crazy cat lady who also loves dogs. She enjoys yoga, indoor soccer and occasional hiking.

Booking information

Duration: 0:45 h
Speaker: Momoko Ito
from 1
54.90 US$
(incl. tax)

You might also be interested in

staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient
Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
Details
tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice
Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
Details
canine-and-feline-lymphoma-diagnosis-and-treatment-1.jpeg
Peter Bennett
0:59 h

Canine and feline lymphoma - diagnosis and treatment
Canine and feline lymphoma is a relatively common disease but there are some areas where potential complications arise. This webinar will concentrate on the diagnostic tests that can be utilised for this disease and the common treatments, with an emphasis on how the diagnostic tests can influence the treatment and prognosis. In dogs, diagnosis is usually relatively straightforward, but it can be more of a challenge in cats due to the differences in clinical presentation. The standard initial treatment options are well described, but how they need to be modified dependent on concurrent illnesses, diagnostic test findings and owner constraints can be more complicated. My approach to these issues will be described including how they might impact the patient outcome, as well as alternatives. The monitoring of the patients and an overview of the management of complications of the disease and treatment is to be covered. The webinar will conclude with rescue options. Lymphoma can be a rewarding disease to treat, but can be very challenging at times.
Details
Back to overview
Webinars & e-learning courses